Literature DB >> 12886962

Clinical characteristics of children with influenza A virus infection requiring hospitalization.

Ying-Hsiang Wang1, Yhu-Chering Huang, Luan-Yin Chang, Hsiu-Tsun Kao, Pen-Yi Lin, Chung-Guei Huang, Tzou-Yien Lin.   

Abstract

From September 1997 to March 2002, a total of 84 children were admitted to Chang Gung Children's Hospital due to influenza A virus infection. Influenza A virus infection was documented in 61 cases by viral isolation from throat and in 23 cases by serologic studies. The mean age of patients was 43.8 months, ranging from 20 days to 16 years. Forty-one (49%) patients were male. Lower respiratory tract infection (53 of 84 cases) was the most common clinical manifestation, occurring predominantly in children younger than 5 years (49 of 53 cases). The types of lower respiratory tract infection included bronchiolitis/bronchopneumonia in 33 cases, pneumonia in 17, and croup in 3. Central nervous system dysfunction was noted in 26 patients, predominantly in older children (18 of 26 cases). This included encephalopathy in 11 cases, encephalitis in 10, aseptic meningitis in 2, psychosis in 1, febrile convulsions in 1, and acute disseminated encephalomyelitis in 1. Gastrointestinal symptoms were mild in most patients. Diarrhea occurred in 18.4% of the children younger than 5 years, compared with only 8.4% of the older children. By contrast, abdominal pain was more common in older children (16.7%) than in younger children (6.7%). Ten children had leukocytosis (white blood cell > or = 15000 /microL) and 9 of them were younger than 5 years. Eleven children had a C-reactive protein level greater than 100 mg/L and 10 of them were younger than 5 years. The mean duration of fever and hospitalization were 4.6 +/- 2.8 days and 7.4 +/- 5.7 days, respectively. The clinical outcomes were excellent in all but 1 patient who died from intractable pulmonary hemorrhage. The frequency and duration of hospitalization due to influenza A virus is much greater than generally thought in Taiwan, suggesting an urgent need for educational programs to increase awareness of the characteristics and risks for this illness.

Entities:  

Mesh:

Year:  2003        PMID: 12886962

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  25 in total

1.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

2.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

3.  Admission diagnoses of children 0-16 years of age hospitalized with influenza.

Authors:  H Silvennoinen; V Peltola; R Vainionpää; O Ruuskanen; T Heikkinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-04       Impact factor: 3.267

4.  Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection.

Authors:  Jeannine A Majde; Stewart G Bohnet; Georgeann A Ellis; Lynn Churchill; Victor Leyva-Grado; Melissa Wu; Eva Szentirmai; Abdur Rehman; James M Krueger
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

5.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

Review 6.  Reducing the burden of influenza-associated complications with antiviral therapy.

Authors:  B R Ruf; T Szucs
Journal:  Infection       Date:  2009-05-26       Impact factor: 3.553

7.  The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.

Authors:  William A Blumentals; Xue Song
Journal:  MedGenMed       Date:  2007-10-30

8.  Influenza virus detection in the stool of children with acute gastroenteritis.

Authors:  Jianling Xie; Xiao-Li Pang; Gillian A M Tarr; Yuan Mu; Ran Zhuo; Linda Chui; Bonita E Lee; Otto G Vanderkooi; Phillip I Tarr; Samina Ali; Shannon E MacDonald; Stephen B Freedman
Journal:  J Clin Virol       Date:  2020-08-01       Impact factor: 3.168

Review 9.  Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Authors:  Stephen Toovey; Craig Rayner; Eric Prinssen; Tom Chu; Barbara Donner; Bharat Thakrar; Regina Dutkowski; Gerhard Hoffmann; Alexander Breidenbach; Lothar Lindemann; Ellen Carey; Lauren Boak; Ronald Gieschke; Susan Sacks; Jonathan Solsky; Ian Small; David Reddy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness.

Authors:  Charisma Dilantika; Endang R Sedyaningsih; Matthew R Kasper; Magdarina Agtini; Erlin Listiyaningsih; Timothy M Uyeki; Timothy H Burgess; Patrick J Blair; Shannon D Putnam
Journal:  BMC Infect Dis       Date:  2010-01-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.